Glutathione overproduction mediates lymphoma initiating cells survival and has a sex-dependent effect on lymphomagenesis
Preprint
- 24 January 2024
- preprint
- Published by Springer Nature in Research Square
Abstract
Lymphoid tumor patients often exhibit resistance to standard therapies or experience relapse post-remission. Relapse is driven by Tumor Initiating Cells (TICs), a subset of tumor cells capable of regrowing the tumor and highly resistant to therapy. Growing cells in 3D gels is a method to discern tumorigenic cells because it strongly correlates with tumorigenicity. The finding that TICs, rather than differentiated tumor cells, grow in 3D gels offers a unique opportunity to unveil TIC-specific signaling pathways and therapeutic targets common to various cancer types. Here, we show that culturing lymphoid cells in 3D gels triggers reactive oxygen species (ROS) production, leading to non-tumor lymphoid cell death while enabling the survival and proliferation of a subset of lymphoma/leukemia cells, TICs or TIC-like cells. Treatment with the antioxidant N-acetylcysteine inhibits this lethality and promotes the growth of primary non-tumor lymphoid cells in 3D gels. Some lymphoma cells escape ROS-induced lethality by boosting antioxidant glutathione production, a response not seen in non-tumor cells. Reducing glutathione production in lymphoma cells, either through pharmacological inhibition of glutamate cysteine ligase (GCL), the enzyme catalyzing the rate-limiting step in glutathione biosynthesis, or via knockdown of GCLC, the GCL catalytic subunit, sharply decreased cell growth in 3D gels and xenografts. Tumor cells from B-cell lymphoma/leukemia patients and l-MYC mice, a B-cell lymphoma mouse model, overproduce glutathione. Importantly, pharmacological GCL inhibition hindered lymphoma growth in female l-MYC mice, suggesting that this treatment holds promise as a therapeutic strategy for female lymphoma/leukemia patients.Keywords
All Related Versions
- Version 1, 2024-01-24, Research Square
- Published version: Cell Death & Disease, 15 (7), 1.
This publication has 40 references indexed in Scilit:
- Soft fibrin gels promote selection and growth of tumorigenic cellsNature Materials, 2012
- Reactive Oxygen Species in Cancer Stem CellsAntioxidants & Redox Signaling, 2012
- A shared gene expression signature in mouse models of EBV-associated and non–EBV-associated Burkitt lymphomaBlood, 2011
- Redefining the relevance of established cancer cell lines to the study of mechanisms of clinical anti-cancer drug resistanceProceedings of the National Academy of Sciences, 2011
- Selective targeting of radiation-resistant tumor-initiating cellsProceedings of the National Academy of Sciences, 2010
- E2F1 Expression Is Deregulated and Plays an Oncogenic Role in Sporadic Burkitt's LymphomaCancer Research, 2009
- Association of reactive oxygen species levels and radioresistance in cancer stem cellsNature, 2009
- The curious case of the tumour virus: 50 years of Burkitt's lymphomaNature Reviews Microbiology, 2008
- A systematic approach to diagnosis of mature T-cell leukemias reveals heterogeneity among WHO categoriesBlood, 2004
- Arrest of 3T3 cells in G1 phase in suspension cultureJournal of Cellular Physiology, 1976